Loading clinical trials...
Loading clinical trials...
This pilot study investigates whether advanced diffusion-weighted MRI (ADW-MRI) can differentiate between true tumor progression (TP) and a pseudoprogression (PsP) in patients with glioblastoma (GBM) ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University Hospital, Basel, Switzerland
NCT07100730 · Neoplastic Disease, Glioblastoma, and more
NCT07420543 · Brain Tumors and/or Solid Tumors Including, Glioblastoma, and more
NCT07417774 · Glioblastoma (GBM)
NCT07472387 · Glioblastoma (GBM)
NCT05431348 · Glioblastoma (GBM)
University Hospital Basel
Basel
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions